According
to the new market research report "Nerve
Repair and Regeneration Market by Application
(Neurorrhaphy, Nerve Grafting, Stem Cell Therapy, Neurostimulation Surgery),
Products (Biomaterials, Nerve Conduits, Nerve Protectors, Nerve Wraps,
Neurostimulation Devices) - Global Forecast to 2022".
Browse and
in-depth TOC on “Nerve
Repair and Regeneration Market”.
In the end user, the nerve repair and regeneration market is segmented into hospitals and clinics, and ambulatory surgical centres. The hospitals and clinics sengment is expected to account for the largest share in the market. The growth is primarily attributed to the increasing incidence of neurological incidence and growth in the number of hospitals in emerging countries.
Request for Free Sample Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=883
By region, the global nerve repair and regeneration market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). While North America holds the largest share of the market in 2017,
Some of the major players operating in the nerve repair and regeneration
market are AxoGen (US), Baxter (US), Boston Scientific (US), LivaNova (UK),
Integra LifeSciences (US), Medtronic (US), Abbott Laboratories (US), Stryker
(US), Nevro (US), Polyganics (Netherlands), and Nuvectra (US).
No comments:
Post a Comment